Expression of E- and N-cadherins in tumor in luminal, primary operable breast cancer without Her2/neu overexpression in postmenopausal women as a prognostic factor
Purpose of the study. Evaluation of the expression of E- and N-cadherins in tumor tissues in postmenopausal patients with primary operable luminal breast cancer (BC) without Her2/neu overexpression for inclusion in the panel of a comprehensive assessment of tumor biological parameters for the diseas...
Saved in:
| Main Authors: | V. V. Tokmakov, E. P. Ulianova, Yu. S. Shatova, A. B. Sagakyants, N. M. Mashchenko, I. A. Novikova, E. M. Nepomnyashchaya, O. G. Shulgina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
QUASAR, LLC
2020-12-01
|
| Series: | Исследования и практика в медицине |
| Subjects: | |
| Online Access: | https://www.rpmj.ru/rpmj/article/view/628 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ADJUVANT CHEMOTHERAPY OF PRIMARY OPERABLE LUMINAL B BREAST CANCER WITHOUT OVEREXPRESSION OF HER2/NEU IN POSTMENOPAUSAL WOMEN: YES OR NO?
by: Yu. S. Shatova, et al.
Published: (2017-12-01) -
The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score
by: Zheng‐Jun Yang, et al.
Published: (2023-02-01) -
MORPHOLOGICAL STUDY OF LUMINAL BREAST CANCER
by: M. V. Zavyalova, et al.
Published: (2016-02-01) -
Prognostic Importance of PTEN and P53 in Aggressive Luminal A Subtype Breast Cancers
by: Öykü Dila Gemci, et al.
Published: (2025-07-01) -
Immunological and molecular genetic characteristics of luminal B breast cancer: a literature review
by: D. A. Ryabchikov, et al.
Published: (2017-02-01)